ETFDH and multiple acyl-CoA dehydrogenase deficiency: Because the two included MADD patients carry genetically distinct deleterious variants of ETFDH (Table S1), it is highly plausible that the shared inability to respond to LPS originates from their deficiencies in ETFDH.